{"url_path":"/sec/cvsi/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1510964/0001193125-26-223967-index.html","accession_number":"0001193125-26-223967","cik":"0001510964","ticker":"CVSI","issuer_name":"CV Sciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1510964/0001193125-26-223967-index.html","primary_entity_key":"0001510964","primary_entity_name":"CV Sciences, Inc."},"word_count":85,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits\n\n(d) Exhibits\n\n \n\nExhibit\n\nNumber\n\nDescription\n\n99.1\n\n \n\n[Press Release of CV Sciences, Inc. dated May 14, 2026](cvsi-ex99_1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n* Filed herewith.\n\n1\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nCV SCIENCES, INC.\n\n \n\nDate: May 14, 2026\n\nBy:\n\n/s/ Joseph Dowling\n\n \n\nJoseph Dowling\n\n \n\nChief Executive Officer\n\n \n\n2"}